Data

New PROTECT III Data Demonstrates Impella® Reduces MACCE at Primary Endpoint

Top Downloads

Abiomed Cardiogenic Shock Protocol


Presentations

Jeffrey J. Popma, MD, Presents Data from PROTECT III Study

Watch this breakfast symposium presentation featuring data from the 2-year study of high-risk PCI patients supported with Impella and IABP

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


10.28.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
11.08.19
Dallas Surgical Skills Workshop
Irving, TX
11.10.19
Complex High Risk Intervention with Hemodynamic Support for Fellows
New York, NY
11.11.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
Data

New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery

The patients were treated with the NCSI protocol, which includes placing the Impella heart pump before revascularization

Training

Attend The Complete Revascularization Summit

Interventionalist seeking to better understand complex PCI in the modern era

Presentations

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study

Navin Kapur outlines the importance of ventricular unloading in management of AMI-Cardiogenic Shock. Watch the full video here: bit.ly/32u5wjk #Impella #WarOnShock pic.twitter.com/QYs74WurxR

From Protected PCI's Twitter

Did you know Abiomed’s Clinical Support Center is available 24/7/365? You can call 1-800-422-8666 to reach a team of clinical experts with years of experience. Thank you to the team for their 24/7 dedication! bit.ly/2ZzUXOh pic.twitter.com/4frqb2D90T

From Abiomed's Twitter